ERBB2 and breast carcinoma: Breast cancer is now classified into subtypes based in theory on gene expression profiles but determined in clinical practice by the expression of estrogen receptor (ER), progesterone receptor (PR), overexpression of human epidermal growth factor receptor 2 (HER2) and the Ki67 proliferation index [17].